• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有证据表明丝氨酸蛋白酶活性的细胞表面定位有助于蛋白酶激活受体 CDCP1 的裂解。

Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1.

机构信息

Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, Qld 4102, Australia.

出版信息

Biol Chem. 2018 Sep 25;399(9):1091-1097. doi: 10.1515/hsz-2017-0308.

DOI:10.1515/hsz-2017-0308
PMID:29447112
Abstract

The cellular receptor CUB domain containing protein 1 (CDCP1) is commonly elevated and functionally important in a range of cancers. CDCP1 is cleaved by serine proteases at adjacent sites, arginine 368 (R368) and lysine 369 (K369), which induces cell migration in vitro and metastasis in vivo. We demonstrate that membrane localization of serine protease activity increases efficacy of cleavage of CDCP1, and that both secreted and membrane anchored serine proteases can have distinct preferences for cleaving at CDCP1-R368 and CDCP1-K369. Approaches that disrupt membrane localization of CDCP1 cleaving serine proteases may interfere with the cancer promoting effects of CDCP1 proteolysis.

摘要

细胞表面受体含 CUB 结构域蛋白 1(CDCP1)在多种癌症中普遍升高且具有重要的功能。丝氨酸蛋白酶在毗邻位点精氨酸 368(R368)和赖氨酸 369(K369)处切割 CDCP1,诱导体外细胞迁移和体内转移。我们证明,丝氨酸蛋白酶活性的膜定位增加了 CDCP1 切割的效力,并且分泌的和膜锚定的丝氨酸蛋白酶都可以对 CDCP1-R368 和 CDCP1-K369 的切割具有不同的偏好。破坏 CDCP1 切割丝氨酸蛋白酶膜定位的方法可能会干扰 CDCP1 蛋白水解的促进癌症的作用。

相似文献

1
Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1.有证据表明丝氨酸蛋白酶活性的细胞表面定位有助于蛋白酶激活受体 CDCP1 的裂解。
Biol Chem. 2018 Sep 25;399(9):1091-1097. doi: 10.1515/hsz-2017-0308.
2
Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.整联蛋白糖蛋白 CUB 结构域包含蛋白 1(CDCP1)的蛋白水解诱导的 N 端细胞外结构域脱落伴随着其 C 端结构域的酪氨酸磷酸化以及Src 和 PKCdelta 的募集。
J Biol Chem. 2010 Aug 20;285(34):26162-73. doi: 10.1074/jbc.M109.096453. Epub 2010 Jun 15.
3
In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.体内切割的 CDCP1 通过与激活的β1 整合素复合并诱导 FAK/PI3K/Akt 迁移信号来促进早期肿瘤扩散。
Oncogene. 2014 Jan 9;33(2):255-68. doi: 10.1038/onc.2012.547. Epub 2012 Dec 3.
4
Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.CDCP1升高预示患者预后不良,并通过促进肿瘤球体形成、细胞迁移和化疗耐药介导卵巢透明细胞癌。
Oncogene. 2016 Jan 28;35(4):468-78. doi: 10.1038/onc.2015.101. Epub 2015 Apr 20.
5
EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface.表皮生长因子抑制跨膜原癌 CDCP1 的组成型内吞作用和棕榈酰化依赖性降解,从而促进其在细胞表面的可用性。
Oncogene. 2015 Mar 12;34(11):1375-83. doi: 10.1038/onc.2014.88. Epub 2014 Mar 31.
6
CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.CUB 结构域蛋白 1 是人胰腺癌细胞的预后因子,促进细胞迁移和细胞外基质降解。
Cancer Res. 2010 Jun 15;70(12):5136-46. doi: 10.1158/0008-5472.CAN-10-0220. Epub 2010 May 25.
7
Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.细胞表面糖蛋白CDCP1在前列腺癌中的表达失调。
Oncotarget. 2015 Dec 22;6(41):43743-58. doi: 10.18632/oncotarget.6193.
8
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.细胞系和患者来源的异种移植模型显示,在高级别浆液性卵巢癌中,CDCP1升高可作为一个靶点。
Br J Cancer. 2016 Feb 16;114(4):417-26. doi: 10.1038/bjc.2015.471. Epub 2016 Feb 4.
9
Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.酪氨酸激酶抑制剂拉帕替尼对含 CUB 结构域蛋白 1(CDCP1)介导的乳腺癌细胞存活和迁移的影响。
Biochem Biophys Res Commun. 2011 Oct 14;414(1):226-32. doi: 10.1016/j.bbrc.2011.09.062. Epub 2011 Sep 17.
10
CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.CUB 结构域包含蛋白 1(CDCP1)激活 Src 以促进黑色素瘤转移。
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1379-84. doi: 10.1073/pnas.1017228108. Epub 2011 Jan 10.

引用本文的文献

1
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1.基于底物偏好的活性探针鉴定能切割受体 CDCP1 的蛋白酶。
Nat Chem Biol. 2021 Jul;17(7):776-783. doi: 10.1038/s41589-021-00783-w. Epub 2021 Apr 15.
2
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.靶向完整和蛋白水解的 CDCP1 用于胰腺导管腺癌的成像和治疗。
Theranostics. 2020 Mar 4;10(9):4116-4133. doi: 10.7150/thno.43589. eCollection 2020.
3
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer.
抗 CDCP1 免疫缀合物用于检测和抑制卵巢癌。
Theranostics. 2020 Jan 12;10(5):2095-2114. doi: 10.7150/thno.30736. eCollection 2020.